...
首页> 外文期刊>Romanian Journal of Morphology and Embryology >Angiogenesis in the human thymoma assessed by subclassification of tumor-associated blood vessels and endothelial cells proliferation
【24h】

Angiogenesis in the human thymoma assessed by subclassification of tumor-associated blood vessels and endothelial cells proliferation

机译:通过肿瘤相关血管的亚分类和内皮细胞增殖评估人胸腺瘤中的血管生成

获取原文
           

摘要

The prognostic value of tumor-associated angiogenesis is still a subject of debate. As microvascular density and the expression of different growth factors were not demonstrated to be good predictors of the response to antiangiogenic and antivascular therapy, there is a strong need to search for more sensitive markers. In the present study we evaluated by double immunohistochemical staining the profile of tumor-associated blood vessels and the rate of endothelial cell proliferation in patients with thymoma (n=38). Results were compared with specimens of normal thymus and from patients with myasthenia gravis. We found a significant increase in the number of immature and intermediate blood vessels in the tumor area of thymoma, regardless the histological type of the tumor. Proliferating endothelial cells were found in 15 cases, and co-expression of Ki67 and CD34 had the highest value in immature vessels. Both blood vessel type and endothelial cell proliferation significantly correlated with invasive thymoma. Based on these findings, it can be assumed that the type of tumor-associated vessel together with endothelial cell proliferation are useful predictors of invasion, immature and intermediate vessels can be targeted with antivascular drugs and endothelial cell proliferation could be used as a good predictor of the response to antiangiogenic therapy.
机译:肿瘤相关血管生成的预后价值仍是争论的话题。由于未证明微血管密度和不同生长因子的表达是抗血管生成和抗血管治疗反应的良好预测指标,因此迫切需要寻找更敏感的标志物。在本研究中,我们通过双重免疫组织化学染色评估了胸腺瘤患者(n = 38)的肿瘤相关血管的分布和内皮细胞增殖的速率。将结果与正常胸腺样本和重症肌无力患者的样本进行比较。我们发现,无论肿瘤的组织学类型如何,胸腺瘤肿瘤区域中未成熟血管和中间血管的数量均显着增加。在15例中发现了增殖的内皮细胞,并且Ki67和CD34的共表达在未成熟血管中具有最高的值。血管类型和内皮细胞增殖均与浸润性胸腺瘤显着相关。基于这些发现,可以假设肿瘤相关血管的类型与内皮细胞的增殖是侵袭的有用预测因子,未成熟和中间的血管可以被抗血管药物作为靶点,并且内皮细胞的增殖可以作为抗肿瘤药物的良好预测因子。对抗血管生成治疗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号